Crossmark Global Holdings Inc. Grows Holdings in Tenet Healthcare Co. (NYSE:THC)

Crossmark Global Holdings Inc. lifted its holdings in Tenet Healthcare Co. (NYSE:THC) by 41.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,731 shares of the company’s stock after purchasing an additional 2,544 shares during the period. Crossmark Global Holdings Inc.’s holdings in Tenet Healthcare were worth $1,102,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Plato Investment Management Ltd acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $28,000. ORG Wealth Partners LLC purchased a new position in Tenet Healthcare during the third quarter valued at $30,000. Financial Management Professionals Inc. grew its position in shares of Tenet Healthcare by 2,222.2% in the third quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock valued at $35,000 after purchasing an additional 200 shares during the period. True Wealth Design LLC acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth about $38,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in Tenet Healthcare by 562.7% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 391 shares of the company’s stock worth $52,000 after buying an additional 332 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other news, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $155.94, for a total transaction of $623,760.00. Following the completion of the transaction, the executive vice president now directly owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.93% of the company’s stock.

Tenet Healthcare Stock Down 2.0 %

NYSE:THC opened at $135.50 on Friday. Tenet Healthcare Co. has a 52 week low of $80.53 and a 52 week high of $171.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35. The stock’s fifty day moving average is $134.94 and its two-hundred day moving average is $147.98. The stock has a market capitalization of $12.89 billion, a price-to-earnings ratio of 4.34, a price-to-earnings-growth ratio of 0.60 and a beta of 2.06.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The business’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.44 earnings per share. Research analysts anticipate that Tenet Healthcare Co. will post 11.37 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. restated an “overweight” rating and issued a $175.00 target price on shares of Tenet Healthcare in a research report on Tuesday, December 17th. Cantor Fitzgerald upped their target price on shares of Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a report on Wednesday, October 30th. Royal Bank of Canada raised their price target on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a report on Friday, November 22nd. Finally, UBS Group upped their price target on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $165.00.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.